Literature DB >> 33948380

Angiogenesis is associated with an attenuated tumor microenvironment, aggressive biology, and worse survival in gastric cancer patients.

Masanori Oshi1,2, Vikas Satyananda1, Fernando A Angarita1, Tae Hee Kim1,3, Yoshihisa Tokumaru1,4, Li Yan5, Ryusei Matsuyama2, Itaru Endo2, Masayuki Nagahashi6, Kazuaki Takabe1,2,3,6,7,8.   

Abstract

Angiogenesis is a cornerstone of cancer as it allows tumors to receive oxygen and nutrients. A high level of angiogenesis within a tumor may therefore be indicative of its aggressiveness. In this study, we examined this hypothesis in gastric cancer. Gene set variation analysis was used to measure the level of angiogenesis in tumors in 1,348 gastric cancer patients using the Hallmark_angiogenesis gene set to score tumor transcriptomes. As we predicted, there was a significant correlation between angiogenesis score and expression of angiogenesis-related genes. The score moderately correlated with abundance of vessel-related stromal cells, fibroblasts and chondrocytes in the tumor microenvironment (TME). Tumors with high score had low infiltration of T helper type 1 and 2 cells but a greater infiltration of M1 macrophages and dendritic cells. They also had enriched expression of gene sets for coagulation, hypoxia, epithelial mesenchymal transition (EMT), and TGF-β signaling. High angiogenesis score was significantly associated with advanced AJCC stage and higher T- but not N-parameters in the TNM staging system. Patients with a high score also had shorter survival. In conclusion, bulk tumor transcriptome-based quantification of tumor angiogenesis using a computational algorithm may serve to identify patients with worse survival in gastric cancer. AJCR
Copyright © 2021.

Entities:  

Keywords:  Angiogenesis; EMT; GSVA; gastric cancer; gene set; prognostic biomarker; survival

Year:  2021        PMID: 33948380      PMCID: PMC8085878     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  9 in total

1.  Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer.

Authors:  Masanori Oshi; Shipra Gandhi; Li Yan; Yoshihisa Tokumaru; Rongrong Wu; Akimitsu Yamada; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2022-05-31       Impact factor: 4.872

2.  Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment.

Authors:  Rongrong Wu; Joy Sarkar; Yoshihisa Tokumaru; Yamato Takabe; Masanori Oshi; Mariko Asaoka; Li Yan; Takashi Ishikawa; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

3.  Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.

Authors:  Rongrong Wu; Shipra Gandhi; Yoshihisa Tokumaru; Mariko Asaoka; Masanori Oshi; Li Yan; Takashi Ishikawa; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2022-07-06       Impact factor: 4.624

4.  Higher intra-tumoral expression of pro-coagulation genes is a predictor of angiogenesis, epithelial mesenchymal transition and worse patient survival in gastric cancer.

Authors:  Masanori Oshi; Joy Sarkar; Yoshihisa Tokumaru; Li Yan; Takashi Kosaka; Hirotoshi Akiyama; Masayuki Nagahashi; Chikara Kunisaki; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

Review 5.  Mesenchymal Stem Cell-Derived Antimicrobial Peptides as Potential Anti-Neoplastic Agents: New Insight into Anticancer Mechanisms of Stem Cells and Exosomes.

Authors:  Kasra Moeinabadi-Bidgoli; Malihe Rezaee; Hamidreza Rismanchi; Mohaddese Malek Mohammadi; Amirhesam Babajani
Journal:  Front Cell Dev Biol       Date:  2022-07-06

6.  Conflicting roles of EGFR expression by subtypes in breast cancer.

Authors:  Masanori Oshi; Shipra Gandhi; Yoshihisa Tokumaru; Li Yan; Akimitsu Yamada; Ryusei Matsuyama; Takashi Ishikawa; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2021-10-15       Impact factor: 5.942

7.  Feasibility and Tolerance of Apatinib plus PD-1 Inhibitors for Previously Treated Advanced Gastric Cancer: A Real-World Exploratory Study.

Authors:  Li-Hua Li; Wen-Chao Chen; Gang Wu
Journal:  Dis Markers       Date:  2022-04-29       Impact factor: 3.434

8.  Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer.

Authors:  Yoshihisa Tokumaru; Masanori Oshi; Michelle R Huyser; Li Yan; Masahiro Fukada; Nobuhisa Matsuhashi; Manabu Futamura; Yukihiro Akao; Kazuhiro Yoshida; Kazuaki Takabe
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

9.  FOXC2-AS1 stabilizes FOXC2 mRNA via association with NSUN2 in gastric cancer cells.

Authors:  Jijun Yan; Juntao Liu; Zhengbin Huang; Wenwei Huang; Jianfa Lv
Journal:  Hum Cell       Date:  2021-07-29       Impact factor: 4.374

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.